Estimations des analystes de Wall Street pour NovaBridge Biosciences (NBP): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2027-03-31 | $-0.03 | ||
| 2026-11-12 | $-0.08 | ||
| 2026-08-20 | $-0.02 | $-0.03 | +20.0% |
| 2026-07-30 | $-0.22 | $-0.01 | -2660.4% |
| 2025-12-18 | $-0.03 | $-0.06 | +58.3% |
| 2025-08-26 | $-0.03 | $-0.06 | +58.3% |
| 2025-05-15 | $-0.02 | $-0.06 | +68.4% |
| 2025-03-31 | $-0.06 | $-0.06 | +0.0% |
Ratios de valorisation
| Prix / Valeur comptable | 0.95 |
| EV / EBITDA | -0.36 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenus | $11.3M | $53.8M | $30.0M | $1.54B | $88.0M | -$10.7M | $4.5M | 0 | 0 |
| Coût des Ventes | 0 | 0 | 0 | 0 | $46.4M | 0 | 0 | 0 | 0 |
| Marge Brute | $11.6M | $53.8M | $30.0M | $1.54B | $41.6M | -$10.7M | $4.5M | 0 | 0 |
| R&D | $267.1M | $426.0M | $840.4M | $984.7M | $190.3M | $155.5M | $114.4M | $158.9M | $9.0M |
| Frais Généraux | $25.4M | $66.4M | $654.6M | $402.4M | $899.9M | $199.9M | $63.9M | $216.5M | $4.5M |
| Charges Opérationnelles | $292.5M | $492.4M | $1.49B | $1.39B | $2.11B | $355.4M | $515.6M | $375.4M | $13.5M |
| Résultat Opérationnel | -$273.9M | -$455.7M | -$1.46B | $155.6M | -$2.07B | -$366.1M | -$511.2M | -$375.4M | -$13.5M |
| EBITDA | -$279.3M | -$431.9M | -$197.3M | $168.3M | -$2.06B | -$356.4M | -$344.2M | -$373.5M | -$13.4M |
| Charges d'Intérêt | $864338 | $1.7M | $427481 | $146480 | 0 | 0 | $101854 | 0 | 0 |
| Résultat Avant Impôts | -$290.7M | -$416.8M | -$1.45B | $483.1M | -$2.33B | -$973.2M | -$1.47B | -$362.7M | -$12.6M |
| Impôts | 0 | $1.7M | 0 | $12.2M | -$494814 | -$5.6M | -$1.26B | 0 | 0 |
| Résultat Net | -$298.2M | -$402.8M | -$1.45B | $470.9M | -$2.33B | -$967.5M | -$1.47B | -$162.3M | -$6.6M |
| BPA | $-5.13 | $-6.92 | $-25.53 | $8.07 | $-30.70 | $-30.38 | $-17.62 | $-4.46 | $-0.16 |
| BPA Dilué | $-5.13 | $-6.92 | $-25.53 | $6.90 | $-30.68 | $-30.38 | $-17.62 | $-4.46 | $-0.16 |
| Actions en Circulation (Diluées) | $58.2M | $58.2M | $58.2M | $68.4M | $76.0M | $82.5M | $83.2M | $81.2M | $41.6M |
Prix
| Prix | $1.57 |
| Capitalisation | $181M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ALT · ANNX · AURA · DMAC · DRTS · DSGN · ENGN
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de NBP: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions